Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DIVA test discovered to detect Johne's disease in goats
"This will support the use of vaccines as part of MAP control programs" - Professor Cath Rees.

Actiphage can differentiate between vaccinated and infected animals.

A new diagnostic test has shown potential to differentiate between vaccinated and infected animals with Johne's disease.

Previously, vaccination of livestock against Johne's disease, an infectious wasting condition affecting ruminants, has been hindered because there is no diagnostic test that can differentiate between vaccinated animals, and those with the disease (DIVA test). 

Researchers have discovered that the Actiphage blood test can differentiate between goats that are naturally infected with Johne's disease, and those with vaccinations. 

This discovery suggests potential for a vaccination programme to protect ruminants from the usually fatal disease. While previous tests to detect infection in vaccinated goats did not work, Actiphage detects live bacteria in a milk or blood sample. Because of this, the test is not affected by vaccination status. 

Professor Cath Rees, from the University of Nottingham, said: “We have now shown that Actiphage is compatible with a range of different methods for purifying white blood cells, demonstrating the versatility of our test and opening up a number of new applications.”

“This study provides evidence that Actiphage can also be used as a DIVA test, allowing us to differentiate between naturally infected and vaccinated animals; this will support the use of vaccines as part of MAP (Mycobacterium avium subspecies paratuberculosis) control programs.”

 

Image (C) PBD Biotech

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.